Meloxicam and Risk of Myocardial Infarction: A Population-Based Cohort Study

Oct-14

Cardiovascular Pharmacoepidemiology

AUTHORS : Dr Deepan Dalal no longer works at Rheumatology, Boston Medical Center – Now at Division of Rheumatology, Brown Physicians Patient Center, 375 Wampanoag Trail, Suite 402, East Providence, RI 02915 – Email: deepan_dalal@brown.edu / deepan.dalal@lifespan.org – Profile: http://www.brownmed.org/provider-info/?ID=1350 OR Dr Maureen Dubreuil, Boston University School of Medicine, Department of Medicine, 650 Albany Street, Boston, MA 02118, Email:mdubreuil@bu.edu / maureen.dubreuil@bmc.org – Profile: https://www.bumc.bu.edu/medicine/profile/maureen-dubreuil/

JOURNAL : Arthritis & Rheumatology

REFERENCE: 66(S10):S361-S362

DOI : 10.1002/art.38914

Read more

More publications

Apr-25

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Diabetes Pharmacoepidemiology

Read more

Feb-25

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Pharmacoepidemiology Rheumatology

Read more

Feb-25

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study

Pharmacoepidemiology Rheumatology

Read more